Ectopic expression of the microtubule-dependent motor protein Eg5 promotes pancreatic tumourigenesis

Journal of Pathology

Volumn 221, Issue 2, 2010, Pages 221-228

  Liu, Min ^a   Wang, Xiuchao ^b   Yang, Yunfan ^a   Li, Dengwen ^a   Ren, He ^b   Zhu, Qigang ^c   Chen, Qiang ^c   Han, Shuyong ^c   Hao, Jihui ^b   Zhou, Jun ^a  

^a NANKAI UNIVERSITY   (China)

^b KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

^c Shanxian Central Hospital   (China)

Author keywords

ATPase activity; Cell proliferation; Eg5; Pancreatic cancer; Tumour formation

Indexed keywords

ADENOSINE TRIPHOSPHATASE; EG5 PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER THERAPY; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PANCREAS CANCER; POLYPLOIDY; PRIORITY JOURNAL; SPINDLE CELL; UPREGULATION;

ADENOSINE TRIPHOSPHATASES; ANIMALS; CELL PROLIFERATION; FEMALE; HUMANS; KINESIN; MICE; MICE, NUDE; MOLECULAR MOTOR PROTEINS; PANCREATIC NEOPLASMS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 77952759760     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2706     Document Type: Article

References (18)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
2. Ghaneh P, Costello E, Neoptolemos JP. Biology and management of pancreatic cancer. Gut 2007; 56: 1134-1152.
3. Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 2006; 20: 1218-1249. (Pubitemid 43727584)
4. Kashina AS, Rogers GC, Scholey JM. The bimC family of kinesins: essential bipolar mitotic motors driving centrosome separation. Biochim Biophys Acta 1997; 1357: 257-271.
5. Valentine MT, Gilbert SP. To step or not to step? How biochemistry and mechanics influence processivity in kinesin and Eg5. Curr Opin Cell Biol 2007; 19: 75-81.
6. Kapitein LC, Peterman EJ, Kwok BH, Kim JH, Kapoor TM, Schmidt CF. The bipolar mitotic kinesin Eg5 moves on both microtubules that it crosslinks. Nature 2005; 435: 114-118.
7. Hansen GM, Justice MJ. Activation of Hex and mEg5 by retroviral insertion may contribute to mouse B-cell leukemia. Oncogene 1999; 18: 6531-6539.
8. Nowicki MO, Pawlowski P, Fischer T, Hess G, Pawlowski T, Skorski T. Chronic myelogenous leukemia molecular signature. Oncogene 2003; 22: 3952-3963. (Pubitemid 36819669)
9. Castillo A, Morse HC 3rd, Godfrey VL, Naeem R, Justice MJ. Overexpression of Eg5 causes genomic instability and tumor formation in mice. Cancer Res 2007; 67: 10138-10147. (Pubitemid 350070785)
10. Kaiser A, Brembeck FH, Nicke B, Wiedenmann B, Riecken EO, Rosewicz S. All-trans-retinoic acid-mediated growth inhibition involves inhibition of human kinesin-related protein HsEg5. J Biol Chem 1999; 274: 18925-18931. (Pubitemid 129519309)
11. Liu M, Yu H, Huo L, Liu J, Li M, Zhou J. Validating the mitotic kinesin Eg5 as a therapeutic target in pancreatic cancer cells and tumor xenografts using a specific inhibitor. Biochem Pharmacol 2008; 76: 169-178.
12. Furukawa T, Duguid WP, Rosenberg L, Viallet J, Galloway DA, Tsao MS. Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am J Pathol 1996; 148: 1763-1770. (Pubitemid 26171674)
13. SakowiczR, FinerJT, BeraudC, CromptonA, LewisE, Fritsch A, et al . Antitumor activity of a kinesin inhibitor. Cancer Res 2004; 64: 3276-3280.
14. Wang H, Liu B, Zhang C, Peng G, Liu M, Li D, et al. Parkin regulates paclitaxel sensitivity in breast cancer via a microtubule-dependent mechanism. J Pathol 2009; 218: 76-85.
15. Hruban RH, Goggins M, Parsons J, Kern SE. Progression model for pancreatic cancer. Clin Cancer Res 2000; 6: 2969-2972.
16. Gordon DM, Roof DM. Degradation of the kinesin Kip1p at anaphase onset is mediated by the anaphase-promoting complex and Cdc20p. Proc Natl Acad Sci U S A 2001; 98: 12515-12520.
17. Germani A, Bruzzoni-Giovanelli H, Fellous A, Gisselbrecht S, Varin-Blank N, Calvo F. SIAH-1 interacts with alpha-tubulin and degrades the kinesin Kid by the proteasome pathway during mitosis. Oncogene 2000; 19: 5997-6006. (Pubitemid 32039375)
18. Duhl DM, Renhowe PA. Inhibitors of kinesin motor proteins - research and clinical progress. Curr Opin Drug Discov Dev 2005; 8: 431-436.